136 related articles for article (PubMed ID: 33852955)
1. DNA methylation as a key epigenetic player for hepatoblastoma characterization.
Rivas M; Aguiar T; Fernandes G; Lemes R; Caires-Júnior L; Goulart E; Telles-Silva K; Maschietto M; Cypriano M; de Toledo S; Carraro D; da Cunha I; da Costa C; Rosenberg C; Krepischi A
Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101684. PubMed ID: 33852955
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of
Beck A; Trippel F; Wagner A; Joppien S; Felle M; Vokuhl C; Schwarzmayr T; Strom TM; von Schweinitz D; Längst G; Kappler R
Clin Epigenetics; 2018; 10():27. PubMed ID: 29507645
[TBL] [Abstract][Full Text] [Related]
3. Identification and experimental validation of druggable epigenetic targets in hepatoblastoma.
Clavería-Cabello A; Herranz JM; Latasa MU; Arechederra M; Uriarte I; Pineda-Lucena A; Prosper F; Berraondo P; Alonso C; Sangro B; García Marin JJ; Martinez-Chantar ML; Ciordia S; Corrales FJ; Francalanci P; Alaggio R; Zucman-Rossi J; Indersie E; Cairo S; Domingo-Sàbat M; Zanatto L; Sancho-Bru P; Armengol C; Berasain C; Fernandez-Barrena MG; Avila MA
J Hepatol; 2023 Oct; 79(4):989-1005. PubMed ID: 37302584
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
Carrillo-Reixach J; Torrens L; Simon-Coma M; Royo L; Domingo-Sàbat M; Abril-Fornaguera J; Akers N; Sala M; Ragull S; Arnal M; Villalmanzo N; Cairo S; Villanueva A; Kappler R; Garrido M; Guerra L; Sábado C; Guillén G; Mallo M; Piñeyro D; Vázquez-Vitali M; Kuchuk O; Mateos ME; Ramírez G; Santamaría ML; Mozo Y; Soriano A; Grotzer M; Branchereau S; de Andoin NG; López-Ibor B; López-Almaraz R; Salinas JA; Torres B; Hernández F; Uriz JJ; Fabre M; Blanco J; Paris C; Bajčiová V; Laureys G; Masnou H; Clos A; Belendez C; Guettier C; Sumoy L; Planas R; Jordà M; Nonell L; Czauderna P; Morland B; Sia D; Losic B; Buendia MA; Sarrias MR; Llovet JM; Armengol C
J Hepatol; 2020 Aug; 73(2):328-341. PubMed ID: 32240714
[TBL] [Abstract][Full Text] [Related]
5. TET Upregulation Leads to 5-Hydroxymethylation Enrichment in Hepatoblastoma.
Rivas MP; Aguiar TFM; Fernandes GR; Caires-Júnior LC; Goulart E; Telles-Silva KA; Cypriano M; de Toledo SRC; Rosenberg C; Carraro DM; da Costa CML; da Cunha IW; Krepischi ACV
Front Genet; 2019; 10():553. PubMed ID: 31249594
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
[TBL] [Abstract][Full Text] [Related]
7. Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma.
Demir S; Razizadeh N; Indersie E; Branchereau S; Cairo S; Kappler R
Hepatol Commun; 2024 Feb; 8(2):. PubMed ID: 38285887
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic basis of hepatoblastoma diversity.
Nagae G; Yamamoto S; Fujita M; Fujita T; Nonaka A; Umeda T; Fukuda S; Tatsuno K; Maejima K; Hayashi A; Kurihara S; Kojima M; Hishiki T; Watanabe K; Ida K; Yano M; Hiyama Y; Tanaka Y; Inoue T; Ueda H; Nakagawa H; Aburatani H; Hiyama E
Nat Commun; 2021 Sep; 12(1):5423. PubMed ID: 34538872
[TBL] [Abstract][Full Text] [Related]
9. Targeting excessive MYCN expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells.
Eberherr C; Beck A; Vokuhl C; Becker K; Häberle B; Von Schweinitz D; Kappler R
Int J Oncol; 2019 May; 54(5):1853-1863. PubMed ID: 30864675
[TBL] [Abstract][Full Text] [Related]
10. RASSF1A methylation indicates a poor prognosis in hepatoblastoma patients.
Honda S; Miyagi H; Suzuki H; Minato M; Haruta M; Kaneko Y; Hatanaka KC; Hiyama E; Kamijo T; Okada T; Taketomi A
Pediatr Surg Int; 2013 Nov; 29(11):1147-52. PubMed ID: 23989600
[TBL] [Abstract][Full Text] [Related]
11. A novel risk stratification model based on the Children's Hepatic Tumours International Collaboration-Hepatoblastoma Stratification and deoxyribonucleic acid methylation analysis for hepatoblastoma.
Kondo T; Honda S; Suzuki H; Ito YM; Kawakita I; Okumura K; Ara M; Minato M; Kitagawa N; Tanaka Y; Tanaka M; Shinkai M; Hishiki T; Watanabe K; Ida K; Takatori A; Hiyama E; Taketomi A
Eur J Cancer; 2022 Sep; 172():311-322. PubMed ID: 35816972
[TBL] [Abstract][Full Text] [Related]
12. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
[TBL] [Abstract][Full Text] [Related]
13. Demethylation Status of Somatic DNA Extracted From Pituitary Neuroendocrine Tumors Indicates Proliferative Behavior.
Szabó B; Németh K; Mészáros K; Szücs N; Czirják S; Reiniger L; Rajnai H; Krencz I; Karászi K; Krokker L; Patócs A; Butz H
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32232382
[TBL] [Abstract][Full Text] [Related]
14. Hepatoblastomas exhibit marked
Rivas MP; Aguiar TFM; Maschietto M; Lemes RB; Caires-Júnior LC; Goulart E; Telles-Silva KA; Novak E; Cristofani LM; Odone V; Cypriano M; de Toledo SRC; Carraro DM; Escobar MQ; Lee H; Johnston M; da Costa CML; da Cunha IW; Tasic L; Pearson PL; Rosenberg C; Timchenko N; Krepischi ACV
Tumour Biol; 2020 Dec; 42(12):1010428320977124. PubMed ID: 33256542
[TBL] [Abstract][Full Text] [Related]
15. Effect of titanium dioxide nanoparticles on DNA methylation in multiple human cell lines.
Pogribna M; Koonce NA; Mathew A; Word B; Patri AK; Lyn-Cook B; Hammons G
Nanotoxicology; 2020 May; 14(4):534-553. PubMed ID: 32031460
[TBL] [Abstract][Full Text] [Related]
16. Clinical prognostic value of DNA methylation in hepatoblastoma: Four novel tumor suppressor candidates.
Honda S; Minato M; Suzuki H; Fujiyoshi M; Miyagi H; Haruta M; Kaneko Y; Hatanaka KC; Hiyama E; Kamijo T; Okada T; Taketomi A
Cancer Sci; 2016 Jun; 107(6):812-9. PubMed ID: 26991471
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression might predict prognosis of epithelial hepatoblastoma.
Gyugos M; Lendvai G; Kenessey I; Schlachter K; Halász J; Nagy P; Garami M; Jakab Z; Schaff Z; Kiss A
Virchows Arch; 2014 Apr; 464(4):419-27. PubMed ID: 24570391
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation in Hepatoblastoma-a literature review.
Shen G; Shen H; Zhang J; Yan Q; Liu H
Ital J Pediatr; 2020 Aug; 46(1):113. PubMed ID: 32758256
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analyses of imprinted differentially methylated regions reveal epigenetic and genetic characteristics in hepatoblastoma.
Rumbajan JM; Maeda T; Souzaki R; Mitsui K; Higashimoto K; Nakabayashi K; Yatsuki H; Nishioka K; Harada R; Aoki S; Kohashi K; Oda Y; Hata K; Saji T; Taguchi T; Tajiri T; Soejima H; Joh K
BMC Cancer; 2013 Dec; 13():608. PubMed ID: 24373183
[TBL] [Abstract][Full Text] [Related]
20. Promoter-specific methylation and expression alterations of igf2 and h19 are involved in human hepatoblastoma.
Li X; Kogner P; Sandstedt B; Haas OA; Ekström TJ
Int J Cancer; 1998 Jan; 75(2):176-80. PubMed ID: 9462704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
